These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 12963980)
1. Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas. Schneider-Stock R; Boltze C; Peters B; Höpfner T; Meyer F; Lippert H; Roessner A Int J Oncol; 2003 Oct; 23(4):1009-13. PubMed ID: 12963980 [TBL] [Abstract][Full Text] [Related]
2. Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues. Kim BN; Yamamoto H; Ikeda K; Damdinsuren B; Sugita Y; Ngan CY; Fujie Y; Ogawa M; Hata T; Ikeda M; Ohue M; Sekimoto M; Monden T; Matsuura N; Monden M Int J Oncol; 2005 May; 26(5):1217-26. PubMed ID: 15809712 [TBL] [Abstract][Full Text] [Related]
3. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding. Prall F; Ostwald C; Weirich V; Nizze H Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer. Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161 [TBL] [Abstract][Full Text] [Related]
5. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Seike M; Gemma A; Hosoya Y; Hemmi S; Taniguchi Y; Fukuda Y; Yamanaka N; Kudoh S Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248 [TBL] [Abstract][Full Text] [Related]
6. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319 [TBL] [Abstract][Full Text] [Related]
7. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related]
8. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Salvesen HB; Das S; Akslen LA Clin Cancer Res; 2000 Jan; 6(1):153-9. PubMed ID: 10656444 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer. Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358 [TBL] [Abstract][Full Text] [Related]
10. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma. Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883 [TBL] [Abstract][Full Text] [Related]
11. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065 [TBL] [Abstract][Full Text] [Related]
12. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer. Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977 [TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849 [TBL] [Abstract][Full Text] [Related]
16. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers. Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369 [TBL] [Abstract][Full Text] [Related]
17. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis. Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762 [TBL] [Abstract][Full Text] [Related]